Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.040

-0.040 (-3.70%)

At close: Aug 29, 2025, 4:00 PM

1.050

+0.010 (0.96%)

After-hours: Aug 29, 2025, 6:46 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2012 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2012 - 2019
Cellular Immunotherapies	13.63M	Log In	Log In	Log In	Log In	Upgrade
Cellular Immunotherapies Growth	-78.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2012 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2012 - 2019
United States	13.63M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-78.55%	Log In	Log In	Log In	Log In	Upgrade